1. Baggio VHW, Ziroldo S, Filling PL (2019) Punctual lip filling. Simetria Harmonization Orofacial in Science 1: 28-39.
2. Christensen L, Breiting V, Janssen M (2005) Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 29: 34-8.
3. Cassuto D, Sundaram H (2013) A Problem-Oriented Approach to Nodular Complications from Hydroxylapatite Fillers: Classification and Recommendations for Treatment. Plast Reconstr Surg 132: 48S-58S.
4. Reig JA, Mur FM, Romeu IP (2010) Are Bacterial Growth and / or Chemotaxis Increased by Filler Injections? Implications for the Pathogenesis and Treatment of Filler-Related Granulomas. Dermatology 221: 356-64.
5. Rodriguez JM, Xie YL, Winthrop KL (2013) Mycobacterium chelonae facial infections following injection of dermal filler. Aesthet Surg J 33: 265-9.
6. Nadarajah JT, Collins M, Raboud J (2012) Infectious Complications of Bio-Alcamid Filler Used for HIV-Related Facial Lipoatrophy. Clin Infect Dis 55: 1568-74.
7. DeLorenzi C (2013) Complications of Injectable Fillers, Part I. Aesthet Surg J 33: 561-75.
8. Agger WA, Mardan A (1995) Pseudomonas aeruginosa Infections of Intact Skin. Clinical Infectious Diseases 20: 302–8.
9. Wang Y, Leng V, Patel V (2017) Injections through skin colonized with Staphylococcus aureus biofilm introduce contamination despite standard antimicrobial preparation procedures. Scientific Reports. 7: 45070.
10. Marusza W, Mlynarczyk G, Olszanski R (2012) Probably biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine 7: 1441-47.
11. Saththianathana (2017) The role of bacterial biofilm in adverse soft-tissue filler reactions: a combined laboratory and clinical study. Plastic and reconstructive surgery, v. 139, n. 3, p. 613-621, 2017.
12. Hexsel D, Morais MR (2014) Management of Complications of Injectable Silicone. Facial Plast Surg 30: 623-27.
13. Sclafani AP, Fagien S (2009) Treatment of injectable soft tissue filler complications. Dermatol Surg 35: 1672-80.
14. Ledon JA, Savas JA, Yang S (2013) Inflammatory Nodules Following Soft Tissue Filler Use: A Review of Causative Agents, Pathology and Treatment Options. Am J Clin Dermatol 14: 401-11.
15. Becker DE, Reed KL (2012) Local anesthetics: review of pharmacological considerations. Anesth Prog 59: 90–102
16. Johnson SM, John BES, Dine AP (2008) Local anesthetics as antimicrobial agents: a review. Surg Infect 9: 205–13.
17. Bazaz BSF, Salt WG (1983) Local anesthetics as antimicrobial agents: structure-action considerations. Microbes 37: 45–64.
18. Razavi BM, Bazzaz BSF (2019) A review and new insights to antimicrobial action of local anesthetics. Eur J Clin Microbiol Infect Dis 38: 991-1002.
19. Olsen KM, Peddicord TE, Campbell GD (2000) Antimicrobial effects of lidocaine in bronchoalveolar lavage fluid. J Antimicrob Chemother 45: 217–9.
20. Lu CW, Lin TY, Shieh JS (2014) Antimicrobial effect of continuous lidocaine infusion in a Staphylococcus aureus-induced wound infection in a mouse model. Ann Plast Surg 73: 598–601.
21. Srisatjaluk RL, Klongnoi B, Wongsirichat N (2016) Antimicrobial effect of topical local anesthetic spray on oral microflora. J Dent Anesth Pain Med 16: 17–24.
22. Parr AM, Zoutman DE, Davidson JSD (1999) Antimicrobial activity of lidocaine against bacteria associated with nosocomial wound infection. Ann Plast Surg 43: 239–45.
23. Kose AA, Karabaggli Y, Kiremitci A (2010) Do local anesthetics have antibacterial effect on Staphylococcus aureus under in vivo conditions? An experimental study. Dermatol Surg 36: 848–52.
24. Bazaz BSF, Salt WG (1983) Local anesthetics as antibacterial agents: effects on cellular respiration and the leakage of cytoplasmic constituents. Microbes 37: 139–49.
25. Schmidt RM, Rosenkranz HS (1970) Antimicrobial activity of local anesthetics: lidocaine and procaine. J Infect Dis 121: 597–607.
26. Alster TS (2007) The lidocaine / tetracaine peel: a novel topical anesthetic for dermatologic procedures in adult patients. Dermatol Surg 33: 1073-81.
27. Cohen JL, Gold MH (2014) Evaluation of the efficacy and safety of a lidocaine and tetracaine (7% / 7%) cream for induction of local dermal anesthesia for facial soft tissue augmentation with hyaluronic Acid. J Clin Aesthet Dermatol 7: 32–7.
28. Soothill JS, Bravery K, HO A, Macqueen S, Collins J, et al. (2009) A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before / after study on a hemopoietic stem cell transplant ward. Am J Infect Control 37: 626–30.
29. Tagliotatto S, Mitsuushii GN (2018) Comparative study between two topical anesthetics in dermatological procedures. Surgical & Cosmetic Dermatology 10: 49-52.
30. Bauer AW, Kirby WMM, Sherris JC, Turck M (1966) Antibiotic Susceptibility Testing by a Standardized Single Disk Method. Ame J Clin Pathol 45: 493-6.
31. American Academy of Dermatology (US) Administrative regulation and evidence-based clinical practice guidelines.
32. Feldman JM, Robertson KC, Turner J (1994) Do agents used for epidural analgesia have antimicrobial properties? Reg Anesth 19: 43-7.
33. Ohsuka S, Ohta M, Masuda K (1994) Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways. Immunol Microbiol 38: 429–34.
34. Collura V, Letellier L (1990) Mechanism of penetration and of action of local anesthetics in Escherichia coli cells. Biochim Biophys Acta 1027: 238-44.
35. Leung Y, Rawal B (1977) Mechanism of action of tetracaine hydrochloride against Pseudomonas aeruginosa. Infect Dis Obstet Gynecol 136: 679–83.
36. Mullin GS, Rubinfeld RS (1997) The antibacterial activity of topical anesthetics. Cornea, New York 16: 662-5.